Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibodies highly increased in patients with thyroid dysfunction.

Wei Bin Wen1, Feng Ying Liu

  • 1First People's Hospital of Yuci District, Jinzhong, Shanxi, China. wenwei980126@163.com

Cellular & Molecular Immunology
|July 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.

Cellular & molecular immunology·2026
Same journal

Targeting SPP1 requires moving beyond ligand blockade.

Cellular & molecular immunology·2026
Same journal

USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation.

Cellular & molecular immunology·2026
Same journal

Itaconate induces noncanonical AIM2-dependent PANoptosis in sepsis.

Cellular & molecular immunology·2026
Same journal

EZH2: an epigenetic governor of T-cell Ca<sup>2+</sup> homeostasis.

Cellular & molecular immunology·2026
Same journal

Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells.

Cellular & molecular immunology·2026

High levels of thyroid hormone receptor antibody (TRAb) in Graves' disease and thyroglobulin antibody (TGAb)/microsomal antibody (TMAb) in Hashimoto's thyroiditis are significant. These antibody levels aid in understanding disease epidemiology and predicting patient relapse.

Area of Science:

  • Endocrinology
  • Immunology
  • Epidemiology

Background:

  • Thyroid diseases, including nodular goiter, thyroid adenoma, Graves' disease, and Hashimoto's thyroiditis, affect a significant portion of the population.
  • Antithyroid antibodies play a crucial role in the pathogenesis and diagnosis of various thyroid conditions.
  • Understanding the epidemiological distribution and prognostic value of these antibodies is essential for effective patient management.

Purpose of the Study:

  • To evaluate the clinical significance of antithyroid antibody levels in patients with thyroid diseases.
  • To determine the prevalence of thyroid hormone receptor antibody (TRAb), microsomal antibody (TMAb), and thyroglobulin antibody (TGAb) in different thyroid conditions.
  • To assess the utility of these antibodies as epidemiological markers and prognostic indicators for disease relapse.

Related Experiment Videos

Main Methods:

  • A study was conducted on 526 patients with thyroid diseases and 292 healthy subjects in Yuci District, Shanxi Province, China.
  • Serum levels of TRAb, TMAb, and TGAb were measured.
  • Patient data included diagnoses (nodular goiter, thyroid adenoma, Graves' disease, Hashimoto's thyroiditis) and demographic information.

Main Results:

  • High antibody positivity rates were observed: 94.6% TMAb, 76.3% TGAb, and 20.4% TRAb in Hashimoto's thyroiditis.
  • Graves' disease showed high positivity for TRAb (90.3%), with 40.0% TMAb and 30.0% TGAb.
  • The female-to-male ratio varied significantly across disease types, with an overall ratio of 15.6:2.0.

Conclusions:

  • Elevated TRAb levels are characteristic of Graves' disease.
  • Elevated TGAb and TMAb levels are significant in Hashimoto's thyroiditis and idiopathic hypothyroidism.
  • These antibody profiles are valuable for understanding the epidemiological basis of thyroid diseases and serve as prognostic indicators for relapse.